X4 Pharmaceuticals, Inc — Director's Dealing 2022

Jun 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2022-06-06

Reporting Person: de Craecker Francoise (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-06	Common Stock	A	6667	—	Acquired	6667	Direct

Footnotes

F1: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date.

F2: Represents unvested RSUs.